Latest News from the School of Graduate Studies

LSUHS Postdoctoral Fellow receives Award from American Heart Association

Mabruka Alfaidi, PhD, Postdoctoral Fellow in Pathology at LSU Health Shreveport, has been selected as a recipient of an American Heart Association Career Development Award. This prestigious award supports highly promising healthcare and academic professionals in the early years of their career by funding innovative research and training to assure the future success of the awardee as a cardiovascular independent scientist.

Read More about LSUHS Postdoctoral Fellow receives Award from American Heart Association
LSU Health Shreveport post-doctoral fellow receives Career Development Award from American Heart Association

BIZ Magazine - Celeste Y.C. Wu, PhD, post-doctoral fellow in the Department of Neurology at LSU Health Shreveport, was awarded the American Heart Association Career Development Award receiving $231,000 in funding.

Read More about LSU Health Shreveport post-doctoral fellow receives Career Development Award from American Heart Association (opens in new window/tab)
Nicholas Goeders, PhD, LSUHS faculty and internationally renowned expert, appointed to JanOne Scientific Advisory Board

PRNewswire — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the appointment of Nicholas E. Goeders, Ph.D. to its Scientific Advisory Board (SAB). Dr. Goeders is considered one of the world’s leaders on the role of stress in drug addiction.

Read More about Nicholas Goeders, PhD, LSUHS faculty and internationally renowned expert, appointed to JanOne Scientific Advisory Board
Rockefeller Foundation announces grant funding to LSUHS to build coalition to detect and respond to pandemic threats

The Rockefeller Foundation - LSU Health Shreveport (LSUHS) is receiving funding ($340,000) from the Rockefeller Foundation. This follows the announcement yesterday of LSUHS being awarded $730,000 to further its work in genomic sequencing of COVID-19 through a NIH supplemental grant.  LSUHS joins Harvard and the Broad Institute at MIT among others in the US Regional Accelerators for Genomic Surveillance.

Read More about Rockefeller Foundation announces grant funding to LSUHS to build coalition to detect and respond to pandemic threats
LSUHS new discovery for Alzheimer’s disease and Dementia

KTAL/KMSS - A team of scientists and clinicians at LSU Health Shreveport made a groundbreaking discovery for Alzheimer’s disease and Dementia. Dr. Karen Stokes said the new finding could be extremely impactful on Alzheimer’s disease because it will allow doctors to detect the disease early and monitor the progression better.

Read More about LSUHS new discovery for Alzheimer’s disease and Dementia (opens in new window/tab)
brain cell image

Los Angeles Times - Scientists have found that the coronavirus that causes COVID-19 is capable of infecting two types of brain cells — neurons and astrocytes. Scientists have been trying to understand why and how it causes these issues in the brain, said study leader Diana Cruz-Topete, a molecular endocrinologist at LSU Health Shreveport.

Read More about Scientists see path for the coronavirus to invade the brain (opens in new window/tab)
New Faculty Spotlight - Dr. Changwon Park

Associate Professor, Dr. Changwon Park is a new addition to the Department of Molecular and Cellular Physiology. The major effort of his lab is to decipher the underlying cellular and molecular mechanisms as to the successful generation of the cardiovascular constituents, namely endothelial, endocardium, cardiomyocytes, and hematopoietic cells that share the multipotent cardiovascular progenitors, FLK1 (also known as VEGFR2) expressing cells.

Read More about New Faculty Spotlight - Dr. Changwon Park
Dr. Yurochko in the lab

LSUHS has received a 5 year grant for $10,529,128 from the National Institute of Health (NIH) to establish a Center of Biomedical Research Excellence, or COBRE. The COBRE funds will establish the Center for Applied Immunology and Pathological Processes (CAIPP), which will operate on the LSU Health Shreveport campus.

Read More about LSU Health Shreveport awarded over $10.5 million for NIH COBRE focusing research on immunology and pathological processes
COVID Variant Hunter: Even Vaccinated Should Keep Wearing Masks

NBC CT - LSU Health Shreveport Virologist Jeremy Kamil told NBC Connecticut Investigates that halting their spread will require other measures. Kamil was among a team of researchers that discovered seven new COVID-19 strains, known as "variants," aside from the variants first identified in the UK, South Africa, and Brazil. 

Read More about COVID Variant Hunter: Even Vaccinated Should Keep Wearing Masks (opens in new window/tab)
Dr. Xiaohong Lu, LSU Health Shreveport

Dr. Xiao-Hong Lu, Assistant Professor of Pharmacology, Toxicology and Neuroscience, received a $750,000 grant from NASA Biological and Physical Sciences Division’s Space Biology Program to develop a novel genetic engineering technology to evaluate the impact of space radiation on the human brain.

Read More about LSU Health Shreveport researcher receives $750K grant from the National Aeronautics and Space Administration
Senator Bill Cassidy, Louisiana

WASHINGTON – U.S. Senator Bill Cassidy, M.D. (R-LA) today announced the U.S. Department of Health and Human Services (HHS) is awarding $4,617,645 to Louisiana State University (LSU) Health Shreveport and LSU and Agricultural and Mechanical (LSU and A&M) College Baton Rouge under the pharmacology, physiology, and biological chemistry research program.

Read More about LSUHS awarded over $2 million by U.S. Department of Health and Human Services for Research (opens in new window/tab)
Pfizer-BioNTech COVID-19 vaccine vial

KSLA 12 - Dr. Robert Rhoads, professor and emeritus chairman of the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, developed key components of the mRNA over years of work. The vaccine uses messenger RNA, or mRNA, which essentially provides instructions to the body on how to fight the novel coronavirus.

Read More about Technology developed at LSU Health Shreveport played key role in COVID-19 vaccine development
LSU Health Shreveport Leads Louisiana  in COVID-19 VIRAL GENOME SEQUENCING

The Emerging Viral Threat (EVT) Lab at LSU Health Shreveport has now sequenced a total 651 Louisiana SARS-CoV-2 virus genomes making them the largest contributor to date of genetic data on SARS-CoV-2 in the state. SARS-CoV-2, which is short for ‘Severe Acute Respiratory Syndrome Coronavirus-2,’ is the virus that causes COVID-19, and viral genome sequencing is contributing to a worldwide effort to fight the ongoing pandemic.

Read More about LSU Health Shreveport Leads Louisiana in COVID-19 VIRAL GENOME SEQUENCING

 

Events in the School of Graduate Studies

News & Events

School of Graduate Studies